Speaker illustration

Associate Professor Camilla Hage

Karolinska University Hospital, Stockholm (Sweden)

Member of:

European Society of Cardiology
Heart Failure Association

I have a clinical and research interest for heart failure with more than 25 years of experience within cardiovascular and heart failure research. I initiate, design, lead and coordinate national and international clinical trials. My research profile is focused on elucidating pathophysiological mechanisms in heart failure and evaluating potential novel treatments. Primarily my interest lies in phenotyping of HFpEF by deep characterization models using imaging, proteomics, metabolomics, transcriptomics and genomics added by traditional epidemiological analyses.

Aspects of heart failure phenotypes and pathophysiology

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session type: Moderated ePosters

Thumbnail

Heart failure with preserved ejection fraction (HFpEF) 1

Event: ESC Congress 2022

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session type: Moderated ePosters

Thumbnail

HFpEF pathophysiology: new cardiac and peripheral mechanisms

Event: ESC Congress 2022

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session type: Abstract Sessions

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb